Skip to Main Content

Paper Details

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.
Nature Communications
82
2020
CD8+, FcR, GARP, GARP-expressing Tregs, PD-1, PD-L1, TGF, TGF- isoform, TGF-1, TGF-1 mAbs, TGF-1, 2 and 3, Tregs, anti, anti-GARP, anti-tumor CD8+ T cells, cancer, human, malignant cell, melanoma, mouse, patients, tumor, tumors

Datasets

Release 1.2